Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · IEX Real-Time Price · USD
0.829
+0.018 (2.19%)
Jul 26, 2024, 3:59 PM EDT - Market closed
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $32.96 million as of July 26, 2024. Its market cap has decreased by -18.42% in one year.
Market Cap
32.96M
Enterprise Value
-75.15M
1-Year Change
-18.42%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $32.96M, a decrease of -95.49%. That is a compound annual growth rate of -60.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 34.40M | -5.23% |
| Dec 29, 2023 | 36.30M | -1.36% |
| Dec 30, 2022 | 36.80M | -81.91% |
| Dec 31, 2021 | 203.40M | -72.18% |
| Mar 31, 2021 | 731.19M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroBo Pharmaceuticals | 34.61M |
| Immuneering | 34.40M |
| Unicycive Therapeutics | 34.34M |
| Exagen | 34.29M |
| Acurx Pharmaceuticals | 34.19M |
| Cyclo Therapeutics | 33.91M |
| Retractable Technologies | 33.83M |
| ReWalk Robotics | 33.13M |